***********************************
Brakke Consulting’s
Animal Health News & Notes for December 6, 2024
Copyright © Brakke Consulting
Editor: Lynn Fondon DVM MBA
************************************
IN THE NEWS:
Brakke Consulting News
Brakke Consulting 2025 Industry Overview ─ Registration Coming Soon!
Earnings News
Chewy
ECO Animal Health Group
Patterson
Other News
Animalcare Group
Bimeda
Biogénesis Bagó
Boehringer Ingelheim
CowManager
IndeVets
Merck
Mopsan
PetMed Express
PetPace
Protect Animal Health
Randlab
Rejuvenate Bio
TelmyVet
Virbac (MEL 500)
Virbac (Mopsan)
Zoetis
*****************************************
Brakke Consulting
2025 Industry Overview
Presented at VMX: Monday, January 27th, 2-4 pm, Hyatt Regency, Plaza Intl Ballroom G
Presented at WVC: Monday, March 3rd , 2-4 pm, Four Seasons Ballroom 4
How did the top animal health companies perform in 2024? What critical issues and new products will impact industry performance in 2025? Answers to these questions and more will be covered at Brakke Consulting’s annual Industry Overview at the VMX and WVC conferences next year. Key topics and presenters include:
- Industry and Top Global Company 2024 Performance, presented by Bob Jones
- Pets and Vets – What Happened in 2024, presented by John Volk
- Parasiticides in Pets – Back to the Future, presented by Darrell Klug
- Regenerative Medicine ─ Future Game-Changing Therapies, presented by Mike McGinley
Also, again at both events, you will be able to hear directly from a panel of top leaders in the animal health industry. Moderated by Paul Casady, the topic for the panel will be “Opportunities and Challenges in 2025.” The panel for VMX and WVC will be announced soon.
This information-packed 2-hour session will be especially valuable for executive leadership, sales and marketing, strategy, and finance managers and for decision makers in the animal health industry.
Click here to register for VMX
Click here to register for WVC
You can also email Amanda McDavid or call at 336-396-3916. Registration cost is $399; there are discounts for multiple attendees from the same company. We look forward to seeing you there!
*********************************************
EARNINGS NEWS RELEASES
- Patterson Companies, Inc. reported operating results for its fiscal 2025 second quarter ended October 26, 2024. Reported net sales in the Animal Health segment were $1.05 billion; internal sales increased 2% compared to the fiscal 2024 second quarter. Animal Health operating income was $29.6 million, an increase of 12%. (company press release)
- Chewy, Inc. released its financial results for the third quarter of fiscal year 2024 ended October 27, 2024. Net sales were $2.88 billion, an increase of 5% year over year. Net income was $3.9 million compared to a net loss of $(35.4) million in the prior-year quarter. (company press release)
- ECO Animal Health Group reported results for the first half of 2025. Revenue was GBP 33.2 million ($42.1 million), down 13% from the prior-year period. Net loss was GBP(1.7) million ($2.2 million), the loss widening by 30% from the first half of 2024. (yahoo.com)
**************************************
COMPANY NEWS RELEASES
- The FDA announced a supplemental approval for Zoetis‘ Simparica and Simparica Trio for the addition of the indication for the treatment and control of Haemaphysalis longicornis (Asian longhorned tick) infestations for one month in dogs, and a supplemental approval for Zoetis’ Revolution Plus for the addition of the indication for the prevention of Dipylidium caninum (tapeworm) infections as a direct result of killing Ctenocephalides felis vector fleas on the treated cat for one month. (FDA)
- The FDA announced a supplemental approval for Merck‘s Bravecto 1-Month for the addition of the indication for the treatment and control of Haemaphysalis longicornis (Asian longhorned tick) infestations for one month in dogs and puppies. (FDA)
- The FDA announced approval for Virbac‘s MEL 500 (generic melengestrol acetate Type A liquid medicated article) for use in heifers. (FDA)
- The FDA announced approval for Bimeda‘s Doracide (generic doramectin topical solution) for use in cattle. (FDA)
- PetMed Express, Inc. announced that its Board of Directors has adopted a limited duration shareholder rights plan to protect the best interests of all PetMeds shareholders. The Board adopted the Rights Plan to protect the investment of shareholders during a period in which it believes shares of the Company do not reflect the inherent value of the business or its long-term growth potential, and during which there have been recent significant accumulations of Company common stock by certain shareholders. (yahoo finance)
- CowManager introduced Youngstock Monitor, the new comprehensive solution for monitoring calf behavior. The system provides real-time alerts for early disease detection and notifies producers when a calf may be falling behind its herdmates. (company press release)
- Veterinarian staffing company IndeVets announced the launch of its General Practitioner Rotating Mentorship Program. The program gives mentees hands-on experience by rotating through different hospitals and gaining exposure to a variety of clinical settings while training under the guidance of at least one seasoned veterinarian mentor. After the six-month paid mentoring program ends, mentees continue to practice as full-time associates with IndeVets. (Veterinary Practice News)
- FRANCE Boehringer Ingelheim announced the launch of its Eurican L4 vaccine to protect dogs against leptospirosis. The new, non-adjuvanted Eurican L4 vaccine provides effective immunity against four key Leptospira serogroup; it is now available to veterinary practices in France, with additional countries in Europe to follow in 2025. (com)
- TURKEY Virbac announced the acquisition of Turkish company Mopsan, specialized in the distribution of petfood and companion animal health products. Financial terms were not disclosed. (globenewswire)
- AUSTRALIA Animalcare Group announced it has entered into a conditional share purchase agreement to acquire Randlab, an Australian equine veterinary business for an enterprise value of A$120 million (US$78 million). Randlab has an extensive portfolio of equine brands and a track record of new product launches. The business generated revenues of A$22.9 million in FY24. (com)
- VIETNAM Biogénesis Bagó announced the opening of a regional office in Vietnam. The biotechnological company currently has production sites in China and South Korea through key partnerships, as well as technical and commercial teams’ representatives in different markets across the region. (acrofan.com)
- CANADA Pet wearables company PetPace announced a partnership with TelmyVet, a veterinary practice telemedicine solutions provider. This collaboration introduces advanced health monitoring and analytics to Canadian pet parents and veterinary professionals, allowing for near real-time insights into their pets’ well-being and transforming how pet parents can access care with their veterinary team. (businesswire)
- TAIWAN Taiwan-based Protect Animal Health announced a licensing agreement with Rejuvenate Bio to develop and commercialize Rejuvenate’s PT-401, a proprietary gene therapy for Myxomatous Mitral Valve Disease (MMVD) in dogs, delivering anti-aging genes to delay heart failure progression across the Asia-Pacific region. (com)
*********************************************
ANIMAL HEALTH STOCK PRICE TRACKER
***********************************
ANIMAL HEALTH NEWS
- US – EQUINE HEALTH Formaldehyde, pentobarbital and oxytocin are among medications that will not be allowed on show grounds with anyone except a veterinarian under a rule change proposed by the U.S. Equestrian Federation’s Veterinary Committee. The list also includes injectable adrenocorticotropic hormone (ACTH), adenosine, magnesium sulfate, melatonin, thiamine, tryptophan and liquid nitrogen. (Vet Advantage)
- US – FOREIGN DISEASE SURVEILLANCE The U.S. Senate passed legislation to support the Beagle Brigade, a specialized group of canine units stationed at airports and ports of entry to prevent the spread of foreign animal diseases. The Beagle Brigade Act provides backing for the U.S. Department of Agriculture’s (USDA) National Detector Dog Training Center, which trains beagles and other skilled dogs to inspect luggage, vehicles, cargo and packages entering the country. (Vet Advantage)
************************************
CORRECTION
Last week, we inadvertently omitted consultant Lourens Havenga from our list of Brakke consultants and employees. We apologize for the oversight and assure you that he is still a part of Brakke Consulting!
************************************
BRAKKE CONSULTING VIEWPOINT
I hope that most of our readers recall that I am one of the newest consultants to join the Brakke Consulting team and that I am in Brazil. So, sometimes I see things from a different hemisphere.
I am also an individual who frequently engages in sports, which benefits both my body and mind. One morning this week, I went for a run in a nearby park and listened to a morning news radio program. An interview with an agribusiness opinion leader caught my attention. He shared his outlook for the coming years, considering the recent surge in exchange rates in Brazil, with a 3% currency depreciation last week and around 20% in 2024.
Brazilian agribusiness will once again benefit from growing international demand for proteins produced here. With increasing protectionism in the U.S. starting in January under the new administration and potential tariffs on Chinese imports, a possible Chinese reaction to U.S. food imports may occur. This dynamic reinforces the positive effect on Brazilian agribusiness: both from a stronger dollar, as Brazil’s exports are sold in local currency, and new demand for Brazil’s proteins from the Chinese market.
Brazil’s agribusiness will continue to be the growth engine of the country’s economy. Changes in the northern hemisphere will likely benefit Brazil from this new market dynamic. If you see an opportunity for growth in your business here in the southern hemisphere, we can help.
Mauri Ronan Moreira
***********************************
YOUR VIEW
Before Thanksgiving, we asked your plans for holiday shopping. Nearly everyone is doing at least some online shopping. Most of you – 72% – said that you will shop mostly online, with some in-store. 16% plan to shop mostly in-store, with some online. 12% are shopping 100% online and only 1% are shopping 100% in-store.
This week
We are all reading about the possible imposition of tariffs on imports to the U.S. by the new administration starting next year. Knowing what you know today, do you think these potential tariffs and changes in trade policies will have an impact on the companies that operate in animal health business in 2025?
English (United States) 
Portuguese